VABIOTECH licenses cell-based japanese encephalitis technology from Inviragen
The Company for Vaccine and Biological Production No.1 (VABIOTECH) and Inviragen, Inc. announced a licensing agreement by which VABIOTECH will acquire rights to Inviragen’s proprietary Japanese encephalitis (JE) technology to produce a cell-derived vaccine.
A cell-based JE vaccine has the potential to offer improved manufacturing consistency and safety due to the reduced contaminant, preservatives and unnecessary excipients present compared to the previous generation of animal-derived JE vaccines. Under the terms of the agreement, VABIOTECH may exclusively develop and commercialize JE vaccine based on this technology in Vietnam, Cambodia and Myanmar. In exchange, Inviragen will receive certain development-based milestone payments from VABIOTECH.
“The technology licensed from Inviragen will help advance our JE vaccine production technology,” commented Professor Dr. Nguyen Thu Van, director general of the Company. "In partnership with the Ministry of Health, we have made great strides to control the spread of JE infection in Vietnam. We look forward to incorporating this vaccine technology from Inviragen into our JE program."
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Bone degradation process within metastatic breast cancer identified
New technique multiplies life span in simple organisms

Final report analytica 2012: Decision-makers announce definite intentions to invest - Live Labs generate a great deal of interest
Category:Medical_Council_of_India
Juvenile_idiopathic_arthritis
Woolly_hair_syndrome
Nomad Bioscience: new plant biotechnology company founded to focus on biomaterials and biopharmaceuticals
Usher_syndrome
Jawaharlal_Institute_of_Postgraduate_Medical_Education_&_Research
Phenytoin
Waardenburg_syndrome
